Royal Australian College of General Practitioners
[pic]
KEY MEDICAL JOURNALS – APRIL 2021
In order for the Library to comply with copyright law, we ask that you please observe the following Copyright limits when you request articles:
“One article may be copied from a journal publication, or more than one article if they relate to the same subject matter (usually 1-2 articles or one article plus a letter or an editorial) providing no more than 10% of the publication is reproduced.”
To request articles you have a number of options:
* Use our online form at: .au/clinical-resources/john-murtagh-library/library-services/send-a-library-request
* Send details of required article(s) by return email to : library@.au or fax to:(03) 8699 0400.
* As always if your request is urgent telephone us on (03) 8699 0519.
Please indicate any preferences for method of delivery of your articles – and include your current postal address if mailing is preferred.
British Medical Journal Vol. 372 No. 8281 February 27 2021
It’s self-interest to share our vaccines globally n536
Covid-19: Vaccine success drives England’s lockdown exit n528
Covid-19: Recognise long covid as occupational disease and compensate frontline workers, say MPs n503
Seven days in medicine: 17-23 February 2021 n517
Sixty seconds on . . . human challenge trials n515
Covid-19: GPs opt to prioritise all patients with learning disabilities for vaccination n510
Covid-19: No evidence that vaccines can affect fertility, says new guidance n509
Covid-19: Hancock’s failure to publish contracts was unlawful n511
Covid-19: Is vaccination roll out reducing cases and deaths in the UK? n506
Covid-19: Plans to share vaccines aren’t enough, says charity n516
Sambadrome marks Brazil’s covid deaths n518
Poverty, health, and covid-19 n376
NHS reforms: politicians will be back in the driving seat n481
Tracking down John Bell: how the case of the Oxford professor exposes a transparency crisis in government n490
Jeremy Farrar: Make vaccine available to other countries as soon as our most vulnerable people have received it
n459
Research
Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials n135
Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis n156
Instrumental variable meta-analysis of aggregated randomized drug trial data for evaluating proposed target mechanisms n346
Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai n256
Comment
Clare Gerada: Loss has become a daily experience in the covid-19 pandemic n496
What makes new variants of SARS-CoV-2 concerning is not where they come from, but the mutations they contain n504
David Oliver: We can support primary care without blaming hospital doctors n502
Helen Salisbury: Debts of gratitude n514
Will calorie labels for food and drink served outside the home improve public health? n40
US policy requires immediate release of records to patients n426
Covid-19: Self-isolation is the weakest link in stopping transmission n455
Doctors faced with impossible rationing decisions must seek legal advice n458
Covid-19: Difficult decisions require reciprocal understanding among decision makers n462
Defer vaccination of people who have had covid-19 n465
Education
Incontinence is lonely and hard to talk about n207
Does self-management of vaginal pessaries improve care for women with pelvic organ prolapse? n310
Atopic dermatitis in children: when topical steroid treatment “does not work” n297
Multiple itchy lesions after recent travel n231
Exercise to survive a heart attack . . . and other stories n470
Lichen amyloidosis of the legs n315
Careers
Why I . . . horse ride n468
British Medical Journal Vol. 372 No. 8282 March 6 2021
Covid 19: Why we can’t risk another wave n609
Government faces legal action over £23m deal involving patient data n587
Seven days in medicine: 24 February to 2 March 2021 n588
Sixty seconds on . . . flu n584
Covid-19: Outcomes worsened in second wave for Pakistanis and Bangladeshis in England n572
Covid-19: Young mother should be allowed to die in “almost unbearable” tragedy, says judge n577
Covid-19: NHS England pledges extra funding to local areas to reduce vaccine inequalities n580
Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study n567
Covid-19: Where are we on vaccines and variants? n597
Low traffic neighbourhoods and population health n443
Covid-19: Keeping schools as safe as possible n524
NHS sickness absence during the covid-19 pandemic n471
Covid-19, trust, and Wellcome: how charity’s pharma investments overlap with its research efforts n556
Home testing HPV kits will be offered to women in England as part of screening trial n537
Portraits of the people who made vaccines possible n595
Research
High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial n355
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study n311
Prophylactic anticoagulation for patients in hospital with covid-19 n487
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study n423
Comment
Matt Morgan: Head, shoulders, knees, and toes—what’s next on the NHS waiting list? n554
“We are setting ourselves on fire to keep everyone else warm”—what does the recovery look like for NHS staff? n569
David Oliver: Has covid-19 shown society’s disregard for old and sick people? n531
Helen Salisbury: Stepping back from vaccination priorities and focusing on minimising the risk of exposure n591
Changing behaviour: an essential component of tackling health inequalities n332
Care homes: reversing decades of policy neglect n562
Cultural challenges are limiting changes to social care n571
Children’s mental health: the UK government needs to be far more ambitious n573
Vaccinating children to prevent long covid? More caution is needed in interpreting current epidemiological data
n520
Protecting children and young people from developing sport associated dementia n546
Coronial necropsies show the indirect damage from covid-19 n529
Housing and health: channel funding where it will bring the most benefit for all n560
Optimal dosing interval for covid-19 vaccines: we need clinical trial evidence and to consider past infection n522
Covid-19 and evolutionary pressure: can we predict which genetic dangers lurk beyond the horizon? n445
Education
Acute covid-19 and multisystem inflammatory syndrome in children n385
How to conduct written online consultations with patients in primary care n264
A boy with purpura on the legs n329
Wolf’s post-herpetic isotopic response n397
Masks, humidity . . . and other stories n540
Careers
Valuing staff in a pandemic: emergency medicine consultant Stevan Bruijns n539
British Medical Journal Vol. 372 No. 8283 March 13 2021
At the end of the covid-19 storm, another one is brewing n673
Covid-19: Booster dose will be needed in autumn to avoid winter surge, says government adviser n664
Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance
n617
Seven days in medicine: 3-9 March 2021 n648
Sixty seconds on . . . Dolly Parton n647
Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest n612
Doctors unlawfully denied drug to girl with spinal muscular atrophy, appeal court rules n641
Covid-19: Highest death rates seen in countries with most overweight populations n623
Covid-19: NHS Test and Trace made no difference to the pandemic, says report n663
NHS pensions: what do changes to the lifetime allowance mean? n660
Doctors unhappy at proposed 1% pay rise for consultants and salaried GPs in England n646
Covid-19: Female doctors felt compelled to step up during the pandemic, says BMA n658
Vitamin D and covid-19 n544
Covid-19 vaccine hesitancy among ethnic minority groups n513
The EMA covid-19 data leak, and what it tells us about mRNA instability n627
How the lessons of previous epidemics helped successful countries fight covid-19 n486
David Oliver: The case for transitional post-acute care n644
Research
Early surgical reconstruction versus rehabilitation with elective delayed reconstruction for patients with anterior cruciate ligament rupture: COMPARE randomised controlled trial n375
Covid-19 deaths in Africa: prospective systematic postmortem surveillance study n334
Covid-19 in Africa n457
Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries n415
Comment
Rammya Mathew: Workforce must be at the centre of covid-19 recovery plans n635
The UK’s PPE procurement scandal reminds us why we need ways to hold ministers to account n639
Helen Salisbury: Dealing with covid trauma and grief n649
Vitamin D supplementation and testing in the UK: costly but ineffective? n484
Mitigating ethnic disparities in covid-19 and beyond: census linkage can help tackle the data deficit n642
Money, market, media, and vaccine nationalism in the pandemic era n630
Poor, biased reporting of daily covid death statistics without perspective creates fear n640
Covid-19 and aerosol transmission: up in the air n636
Jeremy Metters: former deputy chief medical officer and England’s last HM inspector of anatomy n69
Education
Postpartum thyroiditis n495
Enteric fever n437
CME
A 5 year old girl with fever and rash n381
Rash after consumption of game meat n508
Tai chi, sleep quality, . . . and other stories n613
Careers
What should I do if I’m asked to work outside of my practice? n586
British Medical Journal Vol. 372 No. 8284 March 20 2021
Covid-19 dissenters—or the virtue in being less cheerful n731
Covid-19: WHO says rollout of AstraZeneca vaccine should continue, as Europe divides over safety n728
Capsule endoscopies will be trialled in England n692
Seven days in medicine: 10-16 March 2021 n713
Sixty seconds on . . . twins n709
Covid-19: NHS will keep offering vaccinations to those who refuse, says minister n702
Covid vaccine could be rolled out to children by autumn n723
Check covid status when planning emergency bowel surgery, doctors are told n695
Covid-19: Government’s failure to share data and face scrutiny have undermined response, say MPs n717
Nearly all doctors have faced a complaint in their career, survey finds n707
NHS staff’s stress levels rose last year as covid pandemic took its toll n703
Fast track research approval “here to stay,” says regulator n705
Former British Cycling and Team Sky doctor ordered testosterone to improve performance, tribunal finds n711
Covid-19: Chile joins top five countries in world vaccination league n718
Alcohol deaths rise sharply in England and Wales n607
Mental health of children and young people during pandemic n614
Covid-19 has made the obesity epidemic worse, but failed to ignite enough action n411
Research
Trends in obesity and adiposity measures by race or ethnicity among adults in the United States 2011-18: population based study n365
Changes in soft drinks purchased by British households associated with the UK soft drinks industry levy: controlled interrupted time series analysis n254
UK’s sugar tax hits the sweet spot n463
Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study n450
Comment
Partha Kar: NHS progress on diversity will need regulation and fines n694
Children and the return to school: how much should we worry about covid-19 and long covid? n701
David Oliver: The IEA has used covid-19 as another opportunity to brief against the NHS n697
Helen Salisbury: Protocols and plastic aprons n715
How can we improve self-isolation and quarantine for covid-19? n625
Fatal anaphylaxis: making sure all cases are counted n691
Non-steroidal anti-inflammatory drugs can interact with lithium and antidepressants n679
NHS needs more capacity to tackle surgery backlog n696
Covid mutations: honest approach needed from politicians and scientists on pandemic outlook n656
Increasing recruitment into covid-19 trials: fund nursing trials n601
Why test and trace will fail without support for self-isolation: lessons from San Francisco n652
Keep the faith in the NHS workforce n661
Covid-19 trials: allow recruitment by everyone in healthcare, including those not previously involved in research n599
Primary healthcare for a long term and sustainable vaccination strategy n650
Archie Malcolm: distinguished bone pathologist n54
Education
Diagnosing groin lumps n578
Assessing risk for healthcare workers during the covid-19 pandemic n602
The treatment terrifies me more than the diagnosis n543
Acute onset dysphagia and neck pain after eating n512
“Salmon patch” on the eye n555
Timing of surgery for spinal injury . . . and other stories n675
Careers
Why I . . . am a Brownie leader n606
JAMA Vol. 325 No. 9 March 2 2021
An EUA for Bamlanivimab-A Monoclonal Antibody for COVID-19.
pp880-881. doi:10.1001/jama.2020.24415. PMID: 33306087.
Camilleri M.
Diagnosis and Treatment of Irritable Bowel Syndrome: A Review.
pp865-877. doi:10.1001/jama.2020.22532. PMID: 33651094.
Robinson JC.
Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic.
pp825-826. doi:10.1001/jama.2020.25384. PMID: 33443546.
Brown PA, Ji L, Xu X, et al.
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
pp833-842. doi:10.1001/jama.2021.0669. PMID: 33651090.
Ouldali N, Toubiana J, Antona D, et al.
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
pp855-864. doi:10.1001/jama.2021.0694. PMID: 33523115; PMCID: PMC7851757.
Crane MA, Shermock KM, Omer SB, et al.
Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020.
pp883-885. doi:10.1001/jama.2021.0286. PMID: 33480971; PMCID: PMC7823422.
Locatelli F, Zugmaier G, Rizzari C, et al.
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
pp843-854. doi:10.1001/jama.2021.0987. PMID: 33651091.
Stead W.
It's Not Your Fault.
pp827-828. doi:10.1001/jama.2021.0255. PMID: 33651093.
Mirmirani P, Fu J.
Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021.
pp878-879. doi:10.1001/jama.2020.19313. PMID: 33651080.
Jean-Jacques M, Bauchner H.
Vaccine Distribution-Equity Left Behind?
pp829-830. doi:10.1001/jama.2021.1205. PMID: 33512381.
Donzelli A.
The De-adoption of Low-Value Health Care.
pp887-888. doi:10.1001/jama.2020.25515. PMID: 33651084.
Powers BW, Jain SH, Shrank WH.
The De-adoption of Low-Value Health Care-Reply.
p888. doi:10.1001/jama.2020.25518. PMID: 33651087.
Baicker K.
Trade-offs in Public Health Insurance Design.
pp814-815. doi:10.1001/jama.2021.0647. PMID: 33651081.
Livingston EH.
Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
898. doi:10.1001/jama.2021.1375. PMID: 33533893.
Shukla N, Sulis ML.
Blinatumomab for Treatment of Children With High-risk Relapsed B-Cell Acute Lymphoblastic Leukemia. pp830-832. doi:10.1001/jama.2021.1395. PMID: 33651075.
Abbasi J.
Researchers Investigate What COVID-19 Does to the Heart.
pp808-811. doi:10.1001/jama.2021.0107. PMID: 33566089.
Moore JP, Offit PA.
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
pp821-822. doi:10.1001/jama.2021.1114. PMID: 33507218.
Shalev N, Brudney KF, Scherer ML.
Antiretroviral Drug Recommendations for HIV Treatment and Prevention.
pp888-889. doi:10.1001/jama.2020.25987. PMID: 33651085.
Saag MS, Gandhi RT, Sax PE.
Antiretroviral Drug Recommendations for HIV Treatment and Prevention-Reply.
pp889-890. doi:10.1001/jama.2020.25990. PMID: 33651088.
Voelker R.
Import Alert on Hand Sanitizers From South of the Border.
p816. doi:10.1001/jama.2021.1934. PMID: 33651078.
Voelker R.
Rules Finalized for New Tobacco Product Approvals.
p816. doi:10.1001/jama.2021.1478. PMID: 33651076.
Experts Discuss COVID-19-Vaccine Doses, Virus Variants, and More.
pp812-813. doi:10.1001/jama.2021.1101. PMID: 33566091.
Voelker R.
Monthly Injection Is Approved for Patients With HIV.
p816. doi:10.1001/jama.2021.1932. PMID: 33651077.
"A General Practitioner," or All for Mercy's Sake.
p893. doi:10.1001/jama.2020.17822. PMID: 33651082.
Kesselheim AS, Hwang TJ, Avorn J.
Paying for Prescription Drugs in the New Administration.
pp819-820. doi:10.1001/jama.2021.0009. PMID: 33651097.
Honein MA, Barrios LC, Brooks JT.
Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection.
pp823-824. doi:10.1001/jama.2021.0374. PMID: 33497433.
Shepherd JP, Moore SC, Long A, et al.
Association Between COVID-19 Lockdown Measures and Emergency Department Visits for Violence-
Related Injuries in Cardiff, Wales.
pp885-887. doi:10.1001/jama.2020.25511. PMID: 33651083.
Chernew ME, Pany MJ.
Regulation of Health Care Prices: The Case for Backstop Price Caps in Commercial Health Care Markets. pp817-818. doi:10.1001/jama.2020.26821. PMID: 33651096.
You SC, Gupta A, Krumholz HM.
Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention-Reply.
pp890-891. doi:10.1001/jama.2020.26023. PMID: 33651089.
Kim HK, Kubica J, Jeong YH.
Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention. p890. doi:10.1001/jama.2020.26020. PMID: 33651086.
JAMA Vol. 325 No. 10 March 9 2021
Meza R, Jeon J, Toumazis I, et al.
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography:
Modeling Study for the US Preventive Services Task Force.
pp988-997. doi:10.1001/jama.2021.1077. PMID: 33687469.
Maust DT, Strominger J, Kim HM, et al.
Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US. pp952-961. doi:10.1001/jama.2021.1195. PMID: 33687462; PMCID: PMC7944381.
US Preventive Services Task Force, Krist AH, Davidson KW, et al.
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
pp962-970. doi:10.1001/jama.2021.1117. PMID: 33687470.
Jonas DE, Reuland DS, Reddy SM, et al.
Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
pp971-987. doi:10.1001/jama.2021.0377. PMID: 33687468.
Jin J.
Screening for Lung Cancer.
p1016. doi:10.1001/jama.2021.1799. PMID: 33687464.
Lloyd EC, Gandhi TN, Petty LA.
Monoclonal Antibodies for COVID-19.
p1015. doi:10.1001/jama.2021.1225. PMID: 33544136.
Ghogawala Z, Terrin N, Dunbar MR, et al.
Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy: A Randomized Clinical Trial.
pp942-951. doi:10.1001/jama.2021.1233. PMID: 33687463.
Li L, Neuroth LM, Valachovic E, et al.
Association Between Changes in Social Distancing Policies in Ohio and Traffic Volume and Injuries,
January Through July 2020.
pp1003-1006. doi:10.1001/jama.2020.25770. PMID: 33687457.
Cancer of the Lung.
p1010. doi:10.1001/jama.2020.17834. PMID: 33687456.
Hoffman MR.
Trauma Comes Home.
pp937-938. doi:10.1001/jama.2021.0594. PMID: 33687466.
Mohanan M, Malani A, Krishnan K, et al.
Prevalence of SARS-CoV-2 in Karnataka, India.
pp1001-1003. doi:10.1001/jama.2021.0332. PMID: 33538774; PMCID: PMC7863009.
Henderson LM, Rivera MP, Basch E.
Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity. pp939-941. doi:10.1001/jama.2020.26422. PMID: 33687453.
Lanspa MJ, Blagev DP, Callahan SJ.
Use of e-Cigarettes for Smoking Cessation.
p1006. doi:10.1001/jama.2020.27207. PMID: 33687458.
Eisenberg MJ, Hébert-Losier A, Filion KB.
Use of e-Cigarettes for Smoking Cessation-Reply.
pp1006-1007. doi:10.1001/jama.2020.27210. PMID: 33687460.
Kocher RP, Shah S, Navathe AS.
Overcoming the Market Dominance of Hospitals.
pp929-930. doi:10.1001/jama.2021.0079. PMID: 33605976.
Longhurst CA, Kremer B, Maysent PS.
Rapid Implementation of a Vaccination Superstation.
pp931-932. doi:10.1001/jama.2021.0801. PMID: 33507206.
Dafny L.
Addressing Consolidation in Health Care Markets.
pp927-928. doi:10.1001/jama.2021.0038. PMID: 33507224.
Kuehn BM.
Dramatic Cervical Cancer Screening Decline During Pandemic.
p925. doi:10.1001/jama.2021.1977. PMID: 33687473.
Kuehn BM.
More Resources, Community Outreach Needed to Boost Contact Tracing.
p925. doi:10.1001/jama.2021.1575. PMID: 33687472.
Abbasi J.
Saliva Tests Comparable With Nasal Swabs for SARS-CoV-2 Detection.
p924. doi:10.1001/jama.2021.1780. PMID: 33687449.
Abbasi J.
Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient.
p924. doi:10.1001/jama.2021.2493. PMID: 33687450.
Berwick DM, Beckman AL, Gondi S.
The Triple Aim Applied to Correctional Health Systems.
pp935-936. doi:10.1001/jama.2021.0263. PMID: 33555303.
Brooks JT, Butler JC.
Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2.
pp998-999. doi:10.1001/jama.2021.1505. PMID: 33566056.
Abbasi J.
COVID-19 "Liquid Biopsy" Could Offer Monitoring, Prognostic Tool.
p924. doi:10.1001/jama.2021.2496. PMID: 33687451.
Cutler D.
Building Health Care Better Means Reining In Costs.
pp922-923. doi:10.1001/jama.2021.1578. PMID: 33687455.
Oldfield BJ, Tetrault JM, Berland G.
Addiction Screening-The A Star Is Born Movie Series and Destigmatization of Substance Use Disorders. pp915-917. doi:10.1001/jama.2020.25256. PMID: 33687448.
Liu K.
Effect of Emergency Department Care Bundle on Elderly Patients With Acute Heart Failure.
p1007. doi:10.1001/jama.2020.27291. PMID: 33687459.
Freund Y, Gorlicki J.
Effect of Emergency Department Care Bundle on Elderly Patients With Acute Heart Failure-Reply.
pp1007-1008. doi:10.1001/jama.2020.27294. PMID: 33687461.
Hoffman RM, Reuland DS, Volk RJ.
The Centers for Medicare & Medicaid Services Requirement for Shared Decision-making for Lung Cancer Screening.
pp933-934. doi:10.1001/jama.2021.1817. PMID: 33687471.
Rubin R.
The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials. pp918-921. doi:10.1001/jama.2021.0641. PMID: 33599685.
JAMA Vol. 325 No. 11 March 16 2021
Feldstein LR, Tenforde MW, Friedman KG, et al.
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in
Children (MIS-C) Compared With Severe Acute COVID-19.
pp1074-1087. doi:10.1001/jama.2021.2091. PMID: 33625505; PMCID: PMC7905703.
Mendelson SJ, Prabhakaran S.
Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review.
pp1088-1098. doi:10.1001/jama.2020.26867. PMID: 33724327.
Albert CM, Cook NR, Pester J, et al.
Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
pp1061-1073. doi:10.1001/jama.2021.1489. PMID: 33724323.
Steinbaum E.
A Fib.
p1114. doi:10.1001/jama.2020.25268. PMID: 33724325.
Pinto Taylor E.
Somebody's Sunshine.
pp1045-1046. doi:10.1001/jama.2021.1549. PMID: 33724326.
Murai IH, Fernandes AL, Sales LP, et al.
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
pp1053-1060. doi:10.1001/jama.2020.26848. PMID: 33595634; PMCID: PMC7890452.
Yano H, Kinjo M.
Pruritic Rash and Diarrhea.
pp1103-1104. doi:10.1001/jama.2020.24066. PMID: 33724306.
Zhang G, Jazwinski Faust A.
Spontaneous Bacterial Peritonitis.
p1118. doi:10.1001/jama.2020.10292. PMID: 33724324.
Curfman G.
Omega-3 Fatty Acids and Atrial Fibrillation.
p1063. doi:10.1001/jama.2021.2909. PMID: 33724309.
Jaklevic MC.
Helping Manufacturers Navigate Novel Coronavirus Variants.
p1032. doi:10.1001/jama.2021.3006. PMID: 33724312.
Adhikari EH, Spong CY.
COVID-19 Vaccination in Pregnant and Lactating Women.
pp1039-1040. doi:10.1001/jama.2021.1658. PMID: 33555297.
Walensky RP, Walke HT, Fauci AS.
SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
pp1037-1038. doi:10.1001/jama.2021.2294. PMID: 33595644.
Rasmussen SA, Jamieson DJ.
Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
pp1099-1100. doi:10.1001/jama.2021.1683. PMID: 33555287.
Jaklevic MC.
CAR-T Therapy Is Approved for Non-Hodgkin Lymphoma.
p1032. doi:10.1001/jama.2021.3004. PMID: 33724311.
Jaklevic MC.
Device Uses Electrical Stimulation to Control Snoring.
p1032. doi:10.1001/jama.2021.2622. PMID: 33724310.
Flanagin A, Frey T, Christiansen SL, et al.
The Reporting of Race and Ethnicity in Medical and Science Journals: Comments Invited.
pp1049-1052. doi:10.1001/jama.2021.2104. PMID: 33616604.
Kuehn BM.
Most Patients Hospitalized With COVID-19 Have Lasting Symptoms.
p1031. doi:10.1001/jama.2021.2974. PMID: 33724332.
Kozhimannil KB, Henning-Smith C.
Improving Health Among Rural Residents in the US.
pp1033-1034. doi:10.1001/jama.2020.26372. PMID: 33724329.
Kuehn BM.
New WHO Guideline for Treating Chronic Pain in Children.
p1031. doi:10.1001/jama.2021.2976. PMID: 33724333.
Bianchi DW, Kaeser L, Cernich AN.
Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
pp1041-1042. doi:10.1001/jama.2021.1865. PMID: 33566088.
Leaf DE, Ginde AA.
Vitamin D3 to Treat COVID-19: Different Disease, Same Answer.
pp1047-1048. doi:10.1001/jama.2020.26850. PMID: 33595641.
Wilensky GR.
2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
pp1029-1030. doi:10.1001/jama.2021.1046. PMID: 33724314.
Kuehn BM.
Saving Tens of Thousands of Lives by Cutting Air Pollution.
p1031. doi:10.1001/jama.2021.2292. PMID: 33724331.
Uscher-Pines L, Sousa J, Jones M, et al.
Telehealth Use Among Safety-Net Organizations in California During the COVID-19 Pandemic.
pp1106-1107. doi:10.1001/jama.2021.0282. PMID: 33528494; PMCID: PMC7856569.
The Achievement of the Army Medical Department in the World War.
p1115. doi:10.1001/jama.2020.17846. PMID: 33724315.
Sequist TD.
Improving the Health of the American Indian and Alaska Native Population.
pp1035-1036. doi:10.1001/jama.2021.0521. PMID: 33724330.
Shimabukuro TT, Cole M, Su JR.
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
pp1101-1102. doi:10.1001/jama.2021.1967. PMID: 33576785.
Zatonski WA, Zatonski M, Janik-Koncewicz K, et al.
Alcohol-Related Deaths in Poland During a Period of Weakening Alcohol Control Measures.
pp1108-1109. doi:10.1001/jama.2020.25879. PMID: 33724316.
Kolte D, Libby P, Jang IK.
New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes.
pp1043-1044. doi:10.1001/jama.2021.0069. PMID: 33616637.
Bischoff-Ferrari HA, Theiler R, de Godoi Rezende Costa Molino C.
Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults-Reply.
pp1112-1113. doi:10.1001/jama.2021.0304. PMID: 33724322.
Nigg CR, Resnick B, Marquez DX.
Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults.
pp1111-1112. doi:10.1001/jama.2021.0301. PMID: 33724319.
Burtscher J, Millet GP, Burtscher M.
Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults.
pp1110-1111. doi:10.1001/jama.2021.0337. PMID: 33724320.
Baumann CW, Manini TM, Clark BC.
Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults.
p1111. doi:10.1001/jama.2021.0298. PMID: 33724318.
Winter T.
Algorithm to Evaluate Abnormal Liver Function Tests in Liver Transplant Patients.
pp1109-1110. doi:10.1001/jama.2021.0162. PMID: 33724317.
Lee EW, Saab S, Kaldas FM.
Algorithm to Evaluate Abnormal Liver Function Tests in Liver Transplant Patients-Reply.
p1110. doi:10.1001/jama.2021.0165. PMID: 33724321.
Rubin R.
Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
pp1027-1028. doi:10.1001/jama.2021.2264. PMID: 33625462.
JAMA Vol. 325 No. 12 March 23 2021
Feltner C, Wallace IF, Kistler CE, et al.
Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
pp1202-1215. doi:10.1001/jama.2020.24855. PMID: 33755082.
Burns KEA, Rizvi L, Cook DJ, et al.
Ventilator Weaning and Discontinuation Practices for Critically Ill Patients.
pp1173-1184. doi:10.1001/jama.2021.2384. PMID: 33755077.
Lyons SD.
Shelter.
p1229. doi:10.1001/jama.2021.3481. PMID: 33755079.
Janiaud P, Axfors C, Schmitt AM, et al.
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
pp1185-1195. doi:10.1001/jama.2021.2747. PMID: 33635310; PMCID: PMC7911095.
Russotto V, Myatra SN, Laffey JG, et al.
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries.
pp1164-1172. doi:10.1001/jama.2021.1727. PMID: 33755076.
Grams ME, Hoenig MP, Hoorn EJ.
Evaluation of Hypokalemia.
pp1216-1217. doi:10.1001/jama.2020.17672. PMID: 33755054.
Beware, the Sporothrix.
p1230. doi:10.1001/jama.2020.17858. PMID: 33755062.
Bagley SM.
I Am Not Burned Out.
pp1155-1156. doi:10.1001/jama.2021.2861. PMID: 33755080.
US Preventive Services Task Force, Krist AH, Davidson KW, et al.
Screening for Hearing Loss in Older Adults: US Preventive Services Task Force Recommendation Statement. pp1196-1201. doi:10.1001/jama.2021.2566. PMID: 33755083.
Fink D.
Review of Hearing Loss in Children.
pp1223-1224. doi:10.1001/jama.2021.0387. PMID: 33755065.
Lieu JEC, Kenna M, Anne S.
Review of Hearing Loss in Children-Reply.
pp1224-1225. doi:10.1001/jama.2021.0390. PMID: 33755069.
Downey LA, Hayley AC.
Driving Impairment Following Vaporization of Cannabis.
p1225. doi:10.1001/jama.2021.0451. PMID: 33755068.
Tseng PT, Chen MH, Liang CS.
Driving Impairment Following Vaporization of Cannabis.
pp1225-1226. doi:10.1001/jama.2021.0448. PMID: 33755067.
Singh JA.
Driving Impairment Following Vaporization of Cannabis.
p1226. doi:10.1001/jama.2021.0445. PMID: 33755066.
Ramaekers JG, Arkell TR, McGregor IS.
Driving Impairment Following Vaporization of Cannabis-Reply.
pp1226-1227. doi:10.1001/jama.2021.0454. PMID: 33755070.
Slomski A.
Molecular Point-of-Care Test Improved Influenza Care.
p1135. doi:10.1001/jama.2021.3574. PMID: 33755074.
Slomski A.
Better Hypertension Control With Digital Self-monitoring.
p1135. doi:10.1001/jama.2021.3572. PMID: 33755073.
Jin J.
Screening for Hearing Loss in Older Adults.
p1234. doi:10.1001/jama.2021.2513. PMID: 33755078.
Mehta A.
"Self-Portrait as Exit Wounds": A Graphic Story.
pp1127-1129. doi:10.1001/jama.2020.27162. PMID: 33755053.
Angus DC, Gordon AC, Bauchner H.
Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.
pp1159-1161. doi:10.1001/jama.2021.3284. PMID: 33635309.
Sharfstein JM, Goodman JL, Borio L.
The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
pp1153-1154. doi:10.1001/jama.2021.1961. PMID: 33587124.
Kuehn BM.
Sexual Minorities Have Greater COVID-19 Risk Factors.
p1136. doi:10.1001/jama.2021.3356. PMID: 33755087.
Kuehn BM.
Survey-Many High School Students Have Experienced Violence.
p1136. doi:10.1001/jama.2021.2934. PMID: 33755086.
Slomski A.
Virtual Postoperative Visits Noninferior to In-Person Visits.
p1135. doi:10.1001/jama.2021.3570. PMID: 33755072.
Wakefield M.
Federally Qualified Health Centers and Related Primary Care Workforce Issues.
pp1145-1146. doi:10.1001/jama.2021.1964. PMID: 33755085.
Walter K.
When the Human Voice Speaks Volumes About Lung Function.
pp1130-1131. doi:10.1001/jama.2020.22460. PMID: 33502445.
Rubin R.
Another Explanation for Why Cloth Masks Reduce COVID-19 Severity.
p1134. doi:10.1001/jama.2021.2955. PMID: 33755057.
Slomski A.
With Good Adherence, Daily Aspirin May Prevent Pregnancy Loss.
p1135. doi:10.1001/jama.2021.1788. PMID: 33755071.
Olsen Y, Fitzgerald RM, Wakeman SE.
Overcoming Barriers to Treatment of Opioid Use Disorder.
pp1149-1150. doi:10.1001/jama.2021.1741. PMID: 33630021.
Gershengorn HB.
International Variation in Intubation and Extubation Practices and Adverse Events Among Critically Ill Patients Receiving Mechanical Ventilation.
pp1157-1159. doi:10.1001/jama.2021.1178. PMID: 33755055.
Yehia BR, Fihn SD.
Envisioning the Veterans Affairs Health Care System of the Future.
pp1143-1144. doi:10.1001/jama.2021.0961. PMID: 33755084.
Rubin R.
HHS Expands Number of People Who Can Vaccinate Against COVID-19.
p1134. doi:10.1001/jama.2021.3564. PMID: 33755059.
Slomski A.
Polypill Plus Aspirin Effective for Cardiovascular Disease Prevention.
p1135. doi:10.1001/jama.2021.3576. PMID: 33755075.
Gostin LO.
The Coronavirus Pandemic 1 Year On-What Went Wrong?
pp1132-1133. doi:10.1001/jama.2021.3207. PMID: 33755061.
Rubin R.
VA Nursing Homes' History of Infection Control Shortcomings.
p1134. doi:10.1001/jama.2021.3562. PMID: 33755058.
Aggarwal R, Hammond JG, Joynt Maddox KE, et al.
Association Between the Proportion of Black Patients Cared for at Hospitals and Financial Penalties Under Value-Based Payment Programs.
pp1219-1221. doi:10.1001/jama.2021.0026. PMID: 33755063.
Johnston KJ, Meyers DJ, Hammond G, et al.
Association of Clinician Minority Patient Caseload With Performance in the 2019 Medicare Merit-based
Incentive Payment System.
pp1221-1223. doi:10.1001/jama.2021.0031. PMID: 33755064.
Baldwin GT, Seth P, Noonan RK.
Continued Increases in Overdose Deaths Related to Synthetic Opioids: Implications for Clinical Practice.
pp1151-1152. doi:10.1001/jama.2021.1169. PMID: 33571368.
Weimer MB, Wakeman SE, Saitz R.
Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?
pp1147-1148. doi:10.1001/jama.2021.0958. PMID: 33630020.
Yueh B, Piccirillo JF.
Screening for Hearing Loss in Older Adults: Insufficient Evidence Does Not Mean Insufficient Benefit.
pp1162-1163. doi:10.1001/jama.2021.2020. PMID: 33755056.
Lancet Vol. 397 No. 10276 February 27 2021
Taylor HS, Kotlyar AM, Flores VA.
Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.
pp839-852. doi:10.1016/S0140-6736(21)00389-5. PMID: 33640070.
Hofman MS, Emmett L, Sandhu S, et al.
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
pp797-804. doi:10.1016/S0140-6736(21)00237-3. PMID: 33581798.
Cookson R, Doran T, Asaria M, et al.
The inverse care law re-examined: a global perspective.
pp828-838. doi:10.1016/S0140-6736(21)00243-9. PMID: 33640069.
Bath D, Cook J, Govere J, et al.
Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa.
pp816-827. doi:10.1016/S0140-6736(21)00251-8. PMID: 33640068.
Sternberg ED, Cook J, Alou LPA, et al.
Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Côte d'Ivoire: a two-arm, cluster-randomised controlled trial.
pp805-815. doi:10.1016/S0140-6736(21)00250-6. PMID: 33640067.
50 years of the inverse care law.
p767. doi:10.1016/S0140-6736(21)00505-5. PMID: 33640043.
Topol EJ.
What's lurking in your electrocardiogram?
p785. doi:10.1016/S0140-6736(21)00452-9. PMID: 33640054.
Horton R.
Offline: Thinking the pandemic.
p780. doi:10.1016/S0140-6736(21)00514-6. PMID: 33640049.
Chauvin L.
Peruvian COVID-19 vaccine scandal spreads.
p783. doi:10.1016/S0140-6736(21)00508-0. PMID: 33640052.
Peyre M, Vourc'h G, Lefrançois T, et al.
PREZODE: preventing zoonotic disease emergence.
pp792-793. doi:10.1016/S0140-6736(21)00265-8. PMID: 33640059.
Freemantle N, Pagano D.
Concerns with the new SYNTAX score.
p795. doi:10.1016/S0140-6736(21)00223-3. PMID: 33640064.
Skegg D, Gluckman P, Boulton G, et al.
Future scenarios for the COVID-19 pandemic.
pp777-778. doi:10.1016/S0140-6736(21)00424-4. PMID: 33607000; PMCID: PMC7906624.
Zarocostas J.
New WTO leader faces COVID-19 challenges.
p782. doi:10.1016/S0140-6736(21)00507-9. PMID: 33640051.
Adepoju P.
Ebola returns to Guinea and DR Congo.
p781. doi:10.1016/S0140-6736(21)00506-7. PMID: 33640050.
Haines A, Clark H, Phumaphi J, et al.
The Lancet Pathfinder Commission: pathways to a healthy, zero-carbon future-a call for evidence.
p779. doi:10.1016/S0140-6736(21)00460-8. PMID: 33640048.
Hopkins DR, Ijaz K, Weiss AJ, et al.
Certifying Guinea worm eradication in humans and animals.
pp793-794. doi:10.1016/S0140-6736(21)00262-2. PMID: 33640060.
Martin S, Arawi T.
Ensure Palestinians have access to COVID-19 vaccines.
pp791-792. doi:10.1016/S0140-6736(21)00190-2. PMID: 33577758; PMCID: PMC7906633.
Batniji R.
Historical evidence to inform COVID-19 vaccine mandates.
p791. doi:10.1016/S0140-6736(21)00267-1. PMID: 33640058.
Watt G.
Julian Tudor Hart: medical pioneer and social advocate.
pp786-787. doi:10.1016/S0140-6736(21)00453-0. PMID: 33640055.
Owens DC.
Listening to Black women saves Black lives.
pp788-789. doi:10.1016/S0140-6736(21)00367-6. PMID: 33640056.
Haines A, Floss M.
The inverse care law in the Anthropocene epoch.
pp773-774. doi:10.1016/S0140-6736(21)00304-4. PMID: 33640046.
Mercer SW, Patterson J, Robson JP, et al.
The inverse care law and the potential of primary care in deprived areas.
pp775-776. doi:10.1016/S0140-6736(21)00317-2. PMID: 33640047.
Benjamin LA, Phiri T, Simister R, et al.
Recognising HIV infection in systems of care for stroke.
p794. doi:10.1016/S0140-6736(21)00209-9. PMID: 33640063.
Takahashi K, van Klaveren D, Steyerberg EW, et al.
Concerns with the new SYNTAX score - Authors' reply.
pp795-796. doi:10.1016/S0140-6736(21)00195-1. PMID: 33640065.
Hsiang MS, Mumbengegwi D, Chimumbwa J.
Mini-outbreak response for malaria using indoor residual spraying.
pp771-773. doi:10.1016/S0140-6736(21)00426-8. PMID: 33640045.
Blay JY, Fenaux P, Ladenstein R, et al.
Continue rare cancers collaboration with European Reference Networks after Brexit.
p793. doi:10.1016/S0140-6736(21)00264-6. PMID: 33640061.
Hope TA, Calais J.
PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer. pp768-769. doi:10.1016/S0140-6736(21)00349-4. PMID: 33581799.
Daniels JP.
Colombia grants protected status to 1·7 million migrants.
p784. doi:10.1016/S0140-6736(21)00509-2. PMID: 33640053.
Nassiri N, Maas M, Asanad K, et al.
Testicular cancer with neurological symptoms indicates brain metastases.
e7. doi:10.1016/S0140-6736(21)00211-7. PMID: 33640071.
Chanda E.
Averting malaria transmission with lethal house lure intervention.
pp769-771. doi:10.1016/S0140-6736(21)00355-X. PMID: 33640044.
Pandian JD, Kalkonde Y, Sebastian IA, et al.
Recognising HIV infection in systems of care for stroke - Authors' reply.
pp794-795. doi:10.1016/S0140-6736(21)00206-3. PMID: 33640062.
Lancet Vol. 397 No. 10277 March 6 2021
Penninx BW, Pine DS, Holmes EA, et al.
Anxiety disorders.
pp914-927. doi:10.1016/S0140-6736(21)00359-7. PMID: 33581801.
Samra R, Hankivsky O.
Adopting an intersectionality framework to address power and equity in medicine.
pp857-859. doi:10.1016/S0140-6736(20)32513-7. PMID: 33357466.
Meghji J, Mortimer K, Agusti A, et al.
Improving lung health in low-income and middle-income countries: from challenges to solutions.
pp928-940. doi:10.1016/S0140-6736(21)00458-X. PMID: 33631128.
Mato AR, Shah NN, Jurczak W, et al.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
pp892-901. doi:10.1016/S0140-6736(21)00224-5. PMID: 33676628.
Do we care about who cares?
p853. doi:10.1016/S0140-6736(21)00518-3. PMID: 33676613.
Tuna MA, Rothwell PM; Oxford Vascular Study.
Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms:
population-based validation by investigation and prognosis.
pp902-912. doi:10.1016/S0140-6736(20)31961-9. PMID: 33676629.
Voysey M, Costa Clemens SA, Madhi SA, et al.
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
pp881-891. doi:10.1016/S0140-6736(21)00432-3. PMID: 33617777; PMCID: PMC7894131.
Sabroe I, Mather S, Wilson A, et al.
Error, injustice, and physician wellbeing.
pp872-873. doi:10.1016/S0140-6736(21)00512-2. PMID: 33676623.
Roelcke V, Hildebrandt S, Reis S.
Announcing the Lancet Commission on Medicine and the Holocaust: Historical Evidence, Implications for Today, Teaching for Tomorrow.
pp862-864. doi:10.1016/S0140-6736(21)00157-4. PMID: 33513379.
Lauder M, Lightfoot N.
Learning from crises.
pp878-879. doi:10.1016/S0140-6736(21)00376-7. PMID: 33639086.
Samarasekera U.
Robin Shattock: novel vaccine developer.
p870. doi:10.1016/S0140-6736(21)00510-9. PMID: 33676622.
Whitaker DK.
UK COVID-19 public inquiry and lessons from patient safety.
p878. doi:10.1016/S0140-6736(21)00381-0. PMID: 33639087; PMCID: PMC7906636.
Horton R.
Offline: It's time to ask questions and learn lessons.
p865. doi:10.1016/S0140-6736(21)00571-7. PMID: 33676619.
Soe ZW, Oo MM, Wah KS, et al.
Myanmar's health leaders stand against military rule.
p875. doi:10.1016/S0140-6736(21)00457-8. PMID: 33617775.
Usher AD.
Medical oxygen crisis: a belated COVID-19 response.
pp868-869. doi:10.1016/S0140-6736(21)00561-4. PMID: 33676621.
McCurry J.
The 2011 Tōhoku disaster: 10 years on.
pp866-867. doi:10.1016/S0140-6736(21)00560-2. PMID: 33676620.
Hung IFN, Poland GA.
Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.
pp854-855. doi:10.1016/S0140-6736(21)00528-6. PMID: 33676614.
Vimalesvaran S, Ireland J, Khashu M.
Mind your language: respectful language within maternity services.
pp859-861. doi:10.1016/S0140-6736(21)00031-3. PMID: 33676616.
Berk J, Brinkley-Rubinstein L, Murphy M, et al.
MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.
pp877-878. doi:10.1016/S0140-6736(21)00354-8. PMID: 33617772; PMCID: PMC7906645.
Sisa I, Noblecilla E, Orozco F.
Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
p878. doi:10.1016/S0140-6736(21)00357-3. PMID: 33617776; PMCID: PMC7906642.
Amit S, Regev-Yochay G, Afek A, et al.
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
pp875-877. doi:10.1016/S0140-6736(21)00448-7. PMID: 33610193; PMCID: PMC7906709.
Srour SA.
Social action to achieve a dignified life for people with disabilities in the occupied Palestinian territory.
pp861-862. doi:10.1016/S0140-6736(21)00356-1. PMID: 33676617.
Michot JM, Ribrag V.
Pirtobrutinib shows evidence to inaugurate a third generation of BTK inhibitors.
pp855-857. doi:10.1016/S0140-6736(21)00235-X. PMID: 33676615.
Bourgeois G, Richard M, Danset M, et al.
Deficiency of adenosine deaminase 2 diagnosed at 65 years of age.
p913. doi:10.1016/S0140-6736(20)32660-X. PMID: 33676630.
Robertson JFR, Sewell HF, Stewart M.
Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
pp879-880. doi:10.1016/S0140-6736(21)00455-4. PMID: 33617766; PMCID: PMC7906658.
Lancet Vol. 397 No. 10278 March 13 2021
Meric-Bernstam F, Larkin J, Tabernero J, et al.
Enhancing anti-tumour efficacy with immunotherapy combinations.
pp1010-1022. doi:10.1016/S0140-6736(20)32598-8. PMID: 33285141.
Wouters OJ, Shadlen KC, Salcher-Konrad M, et al.
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
pp1023-1034. doi:10.1016/S0140-6736(21)00306-8. PMID: 33587887; PMCID: PMC7906643.
Erlinge D, Maehara A, Ben-Yehuda O, et al.
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.
pp985-995. doi:10.1016/S0140-6736(21)00249-X. PMID: 33714389.
GBD 2019 Hearing Loss Collaborators.
Hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease Study 2019.
pp996-1009. doi:10.1016/S0140-6736(21)00516-X. PMID: 33714390.
Davies M, Færch L, Jeppesen OK, et al.
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
pp971-984. doi:10.1016/S0140-6736(21)00213-0. PMID: 33667417.
Latini R, Staszewsky L.
Semaglutide and effective weight control.
pp942-943. doi:10.1016/S0140-6736(21)00377-9. PMID: 33667415.
Roe N.
John Keats, medicine, and poetry.
pp962-963. doi:10.1016/S0140-6736(21)00450-5. PMID: 33631129.
Access to COVID-19 vaccines: looking beyond COVAX.
p941. doi:10.1016/S0140-6736(21)00617-6. PMID: 33714374.
Jeudy JM, Ciancio G.
Haiti's kidney transplantation unit.
p970. doi:10.1016/S0140-6736(21)00353-6. PMID: 33714387.
Sharma N.
Clinician engineers-the time is now.
p967. doi:10.1016/S0140-6736(21)00444-X. PMID: 33714382.
Vijayasingham L, Bischof E, Wolfe J.
Sex-disaggregated data in COVID-19 vaccine trials.
pp966-967. doi:10.1016/S0140-6736(21)00384-6. PMID: 33684351; PMCID: PMC7952097.
Lokugamage AU, Wong SHM, Robinson NMA, et al.
Transformational learning to decolonise global health.
pp968-969. doi:10.1016/S0140-6736(21)00371-8. PMID: 33714384.
Olusanya BO.
Accountability framework to decolonise global health.
p968. doi:10.1016/S0140-6736(21)00378-0. PMID: 33714383.
Commissioners of the Lancet COVID-19 Commission.
Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
pp947-950. doi:10.1016/S0140-6736(21)00388-3. PMID: 33587888; PMCID: PMC7906747.
Fontanet A, Autran B, Lina B, et al.
SARS-CoV-2 variants and ending the COVID-19 pandemic.
pp952-954. doi:10.1016/S0140-6736(21)00370-6. PMID: 33581803; PMCID: PMC7906631.
Devi S.
Health in Syria: a decade of conflict.
pp955-956. doi:10.1016/S0140-6736(21)00618-8. PMID: 33714377.
Wilson BS, Tucci DL.
Addressing the global burden of hearing loss.
pp945-947. doi:10.1016/S0140-6736(21)00522-5. PMID: 33714376.
Holt E.
Countries split from EU on COVID-19 vaccines.
p958. doi:10.1016/S0140-6736(21)00620-6. PMID: 33714379.
Lane R.
Yashica Robinson: championing reproductive health in Alabama.
p961. doi:10.1016/S0140-6736(21)00565-1. PMID:33714380.
Goddard AF, Patel M.
The changing face of medical professionalism and the impact of COVID-19.
pp950-952. doi:10.1016/S0140-6736(21)00436-0. PMID: 33636125; PMCID: PMC7906722.
Kho SS, Ho YF, Chan SK, et al.
Mediastinal melioidosis masquerading as malignancy of the lung.
e8. doi:10.1016/S0140-6736(21)00200-2. PMID: 33714391.
Aucott JN, Rebman AW.
Long-haul COVID: heed the lessons from other infection-triggered illnesses.
pp967-968. doi:10.1016/S0140-6736(21)00446-3. PMID: 33684352; PMCID: PMC7952095.
Cousins S.
Australian Commission calls for overhaul of aged care.
p957. doi:10.1016/S0140-6736(21)00619-X. PMID: 33714378.
Waksman R, Torguson R.
The vulnerable plaque detected: time to consider treatment.
pp943-945. doi:10.1016/S0140-6736(21)00504-3. PMID: 33714375.
Murakami M, Tsubokura M.
Deepening community-aligned science in response to wavering trust in science.
pp969-970. doi:10.1016/S0140-6736(21)00358-5. PMID: 33714385.
Madad S, Spencer C.
The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response.
pp965-966. doi:10.1016/S0140-6736(21)00433-5. PMID: 33684353; PMCID: PMC7952086.
Lancet Vol. 397 No. 10279 March 20 2021
Beyrer C, Adimora AA, Hodder SL, et al.
Call to action: how can the US Ending the HIV Epidemic initiative succeed?
pp1151-1156. doi:10.1016/S0140-6736(21)00390-1. PMID: 33617770.
Hodder SL, Feinberg J, Strathdee SA, et al.
The opioid crisis and HIV in the USA: deadly synergies.
pp1139-1150. doi:10.1016/S0140-6736(21)00391-3. PMID: 33617769.
Mayer KH, Nelson L, Hightow-Weidman L, et al.
The persistent and evolving HIV epidemic in American men who have sex with men.
pp1116-1126. doi:10.1016/S0140-6736(21)00321-4. PMID: 33617771.
Adimora AA, Ramirez C, Poteat T, et al.
HIV and women in the USA: what we know and where to go from here.
pp1107-1115. doi:10.1016/S0140-6736(21)00396-2. PMID: 33617768.
Sullivan PS, Satcher Johnson A, Pembleton ES, et al.
Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.
pp1095-1106. doi:10.1016/S0140-6736(21)00395-0. PMID: 33617774.
Kates J, Dawson L, Horn TH, et al.
Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
pp1127-1138. doi:10.1016/S0140-6736(21)00397-4. PMID: 33617778.
Figtree GA, Vernon ST, Hadziosmanovic N, et al.
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
pp1085-1094. doi:10.1016/S0140-6736(21)00272-5. PMID: 33711294.
He Z, Ren L, Yang J, et al.
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
pp1075-1084. doi:10.1016/S0140-6736(21)00238-5. PMID: 33743869.
PRINCIPLE Trial Collaborative Group.
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
pp1063-1074. doi:10.1016/S0140-6736(21)00461-X. PMID: 33676597; PMCID: PMC7972318.
Myanmar's democracy and health on life support.
pp1035. doi:10.1016/S0140-6736(21)00656-5. PMID: 33743852.
Pigeolet M, Jayaram A, Park KB, et al.
Osteoarthritis in 2020 and beyond.
pp1059-1060. doi:10.1016/S0140-6736(21)00208-7. PMID: 33743863.
Hunter DJ, March L, Chew M.
Osteoarthritis in 2020 and beyond - Authors' reply.
p1060. doi:10.1016/S0140-6736(21)00205-1. PMID: 33743864.
Gill PS, Poduval S, Thakur JS, Iqbal R.
COVID-19, community trials, and inclusion.
pp1036-1037. doi:10.1016/S0140-6736(21)00661-9. PMID: 33743853.
Doshi P, Hong K, Jefferson T, et al.
Control vaccine formulation.
pp1061-1062. doi:10.1016/S0140-6736(21)00382-2. PMID: 33743866.
Saah AJ, Muñoz N.
Control vaccine formulation - Authors' reply.
p1062. doi:10.1016/S0140-6736(21)00437-2. PMID: 33743868.
Watts G.
Dame Fiona Caldicott.
p1056. doi:10.1016/S0140-6736(21)00586-9. PMID: 33743859.
Crisp N.
Human flourishing in a health-creating society.
pp1054-1055. doi:10.1016/S0140-6736(21)00585-7. PMID: 33743858.
Devi S.
Aid agencies turn attention to diabetes.
pp1049-1050. doi:10.1016/S0140-6736(21)00658-9. PMID: 33743856.
Lønnebakken MT.
The risk of no risk in STEMI.
pp1039-1040. doi:10.1016/S0140-6736(21)00375-5. PMID: 33711295.
Lane R.
Chris Butler: primary care research supremo.
p1051. doi:10.1016/S0140-6736(21)00583-3. PMID: 33743857.
Klaassen T, Keszthelyi D.
Satiation or satiety? More than mere semantics.
pp1060-1061. doi:10.1016/S0140-6736(21)00245-2. PMID: 33743865.
Carbone MF, Mahadeva S, Lacy BE, et al.
Satiation or satiety? More than mere semantics - Authors' reply.
p1061. doi:10.1016/S0140-6736(21)00239-7. PMID: 33743867.
Gedela K.
Undoing supremacy in global health will require more than decolonisation.
p1058. doi:10.1016/S0140-6736(21)00383-4. PMID: 33743861.
Allotey P, Reidpath DD.
Undoing supremacy in global health will require more than decolonisation.
p1058. doi:10.1016/S0140-6736(21)00379-2. PMID: 33743860.
Abimbola S, Pai M.
Undoing supremacy in global health will require more than decolonisation - Authors' reply.
pp1058-1059. doi:10.1016/S0140-6736(21)00373-1. PMID: 33743862.
Rushton J, Huntington B, Gilbert W, et al.
Roll-out of the Global Burden of Animal Diseases programme.
pp1045-1046. doi:10.1016/S0140-6736(21)00189-6. PMID: 33549170.
Manisty C, Otter AD, Treibel TA, et al.
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
pp1057-1058. doi:10.1016/S0140-6736(21)00501-8. PMID: 33640038; PMCID: PMC7972310.
Fields EL, Copeland R, Hopkins E.
Same script, different viruses: HIV and COVID-19 in US Black communities.
pp1040-1042. doi:10.1016/S0140-6736(20)32522-8. PMID: 33617773.
Jaffe S.
Biden's first legislative victory: $1·9 trillion for COVID-19.
pp1047-1048. doi:10.1016/S0140-6736(21)00657-7. PMID: 33743855.
Rodriguez-Diaz CE, Martinez O, Bland S, et al.
Ending the HIV epidemic in US Latinx sexual and gender minorities.
pp1043-1045. doi:10.1016/S0140-6736(20)32521-6. PMID: 33617767.
Steinberg J, Thomas A, Iravani A.
18F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
e9. doi:10.1016/S0140-6736(21)00464-5. PMID: 33705696; PMCID: PMC7972305.
Strugnell R, Wang N.
Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2. pp1037-1039. doi:10.1016/S0140-6736(21)00434-7. PMID: 33743854.
Medical Journal of Australia Vol. 214 No. 4 March 2021
Dive L, Newson AJ.
Ethical issues in reproductive genetic carrier screening.
pp165-167.e1. doi:10.5694/mja2.50789. PMID: 32981044.
Gidding HF, Machalek DA, Hendry AJ, et al.
Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020.
pp179-185. doi:10.5694/mja2.50940. PMID: 33538019.
Objectives: To estimate SARS-CoV-2-specific antibody seroprevalence after the first epidemic wave of coronavirus disease 2019 (COVID-19) in Sydney.
Setting, participants: People of any age who had provided blood for testing at selected diagnostic pathology services (general pathology); pregnant women aged 20-39 years who had received routine antenatal screening; and Australian Red Cross Lifeblood plasmapheresis donors aged 20-69 years.
Design: Cross-sectional study; testing of de-identified residual blood specimens collected during 20 April - 2 June 2020.
Main outcome measure: Estimated proportions of people seropositive for anti-SARS-CoV-2-specific IgG, adjusted for test sensitivity and specificity.
Results: Thirty-eight of 5339 specimens were IgG-positive (general pathology, 19 of 3231; antenatal screening, 7 of 560; plasmapheresis donors, 12 of 1548); there were no clear patterns by age group, sex, or location of residence. Adjusted estimated seroprevalence among people who had had general pathology blood tests (all ages) was 0.15% (95% credible interval [CrI], 0.04-0.41%), and 0.29% (95% CrI, 0.04-0.75%) for plasmapheresis donors (20-69 years). Among 20-39-year-old people, the age group common to all three collection groups, adjusted estimated seroprevalence was 0.24% (95% CrI, 0.04-0.80%) for the general pathology group, 0.79% (95% CrI, 0.04-1.88%) for the antenatal screening group, and 0.69% (95% CrI, 0.04-1.59%) for plasmapheresis donors.
Conclusions: Estimated SARS-CoV-2 seroprevalence was below 1%, indicating that community transmission was low during the first COVID-19 epidemic wave in Sydney. These findings suggest that early control of the spread of COVID-19 was successful, but efforts to reduce further transmission remain important.
Wichmann MW, McCullough TK, Beukes E, et al.
Colorectal cancer surgery in rural Australia can match outcomes in metropolitan hospitals: a 14-year study.
pp186-187. doi:10.5694/mja2.50852. PMID: 33165942.
Scheetz J, He M, van Wijngaarden P.
Ophthalmology and the emergence of artificial intelligence.
pp155-157.e1. doi:10.5694/mja2.50932. PMID: 33583047.
Gupta S, Sidhu M, Banh X, et al.
A prospective multicentre study of per-oral endoscopic myotomy (POEM) for achalasia in Australia.
pp173-178. doi:10.5694/mja2.50941. PMID: 33611796.
Fan H, Yu L.
Tracheal obstruction caused by pleomorphic adenoma.
p163.e1. doi:10.5694/mja2.50920. PMID: 33423289.
Chuah YY, Lee YY.
Cullen and Grey Turner signs in abdominal pain.
p164. doi:10.5694/mja2.50924. PMID: 33458825.
Holmwood CB.
Screening and brief interventions for harmful alcohol use: where to now?
pp153-154.e1. doi:10.5694/mja2.50927. PMID: 33486787.
Thomas J, Harraway J, Kirchhoffer D.
Non-invasive prenatal testing: clinical utility and ethical concerns about recent advances.
pp168-170.e1. doi:10.5694/mja2.50928. PMID: 33423294.
Tiller J, Winship I, Otlowski MF, et al.
Monitoring the genetic testing and life insurance moratorium in Australia: a national research project.
pp157-159.e1. doi:10.5694/mja2.50922. PMID: 33550592.
Swannell C.
Full list of Australia Day Honours.
C1-C2. doi:10.5694/mja2.50951. PMID: 33641172.
Cook IJ.
POEM for achalasia: Looking good, but the final verses are yet to be penned.
pp171-172. doi:10.5694/mja2.50945. PMID: 33641178.
joint ACTA/ACSQHC Working Group.
The value proposition of investigator-initiated clinical trials conducted by networks.
pp159-161.e1. doi:10.5694/mja2.50935. PMID: 33583043.
Gray DJ, Williams GM, McManus DP.
COVID-19, children and schools: overlooked and at risk.
p188.e1. doi:10.5694/mja2.50937. PMID: 33641174.
Munro A, Bowen AC, Cevik M.
COVID-19, children and schools: overlooked and at risk.
p188.e1. doi:10.5694/mja2.50933. PMID: 33641173.
Hyde Z.
COVID-19, children and schools: overlooked and at risk.
pp190-191.e1. doi:10.5694/mja2.50934. PMID: 33641177.
Ryan KE, Goldfield S, Danchin MH, et al.
COVID-19, children and schools: overlooked and at risk.
p189.e1. doi:10.5694/mja2.50936. PMID: 33641176.
Heriot GS, Jamrozik E.
Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere.
pp150-152.e1. doi:10.5694/mja2.50930. PMID: 33550606.
Britton PN, Koirala A, Wood N, et al.
COVID-19, children and schools: overlooked and at risk.
p189.e1. doi:10.5694/mja2.50938. PMID: 33641179.
Fernando SL, Capon MJ, Green SL, et al.
Pharmacovigilance for chlorhexidine anaphylaxis: a preventable adverse reaction.
pp162-163.e1. doi:10.5694/mja2.50929. PMID: 33527357.
Medical Journal of Australia Vol. 214 No. 5 March 2021
Ralph AP, Noonan S, Wade V, et al.
The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.
pp220-227. doi:10.5694/mja2.50851. PMID: 33190309.
Introduction: Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) cause significant morbidity and premature mortality among Australian Aboriginal and Torres Strait Islander peoples. RHDAustralia has produced a fully updated clinical guideline in response to new knowledge gained since the 2012 edition. The guideline aligns with major international ARF and RHD practice guidelines from the American Heart Association and World Heart Federation to ensure best practice. The GRADE system was used to assess the quality and strength of evidence where appropriate.
Main recommendations: The 2020 Australian guideline details best practice care for people with or at risk of ARF and RHD. It provides up-to-date guidance on primordial, primary and secondary prevention, diagnosis and management, preconception and perinatal management of women with RHD, culturally safe practice, provision of a trained and supported Aboriginal and Torres Strait Islander workforce, disease burden, RHD screening, control programs and new technologies.
Changes in management as a result of the guideline: Key changes include updating of ARF and RHD diagnostic criteria; change in secondary prophylaxis duration; improved pain management for intramuscular injections; and changes to antibiotic regimens for primary prevention. Other changes include an emphasis on provision of culturally appropriate care; updated burden of disease data using linked register and hospitalisations data; primordial prevention strategies to reduce streptococcal infection addressing household overcrowding and personal hygiene; recommendations for population-based echocardiographic screening for RHD in select populations; expanded management guidance for women with RHD or ARF to cover contraception, antenatal, delivery and postnatal care, and to stratify pregnancy risks according to RHD severity; and a priority classification system for presence and severity of RHD to align with appropriate timing of follow-up.
Douglas NM, Meumann EM, Krause VL, et al.
Successful containment to date of SARS-CoV-2 transmission in the Northern Territory.
pp218-219. doi:10.5694/mja2.50840. PMID: 33111312.
Beilby J.
The general practitioner and the pharmacist: a policy enigma?
pp210-211. doi:10.5694/mja2.50957. PMID: 33634476.
Freeman CR, Scott IA, Hemming K, et al.
Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME): a stepped wedge, cluster randomised controlled trial.
pp212-217. doi:10.5694/mja2.50942. PMID: 33580553.
Objective: To investigate whether integrating pharmacists into general practices reduces the number of unplanned re-admissions of patients recently discharged from hospital.
Design, setting: Stepped wedge, cluster randomised trial in 14 general practices in southeast Queensland.
Participants: Adults discharged from one of seven study hospitals during the seven days preceding recruitment (22 May 2017 - 14 March 2018) and prescribed five or more long term medicines, or having a primary discharge diagnosis of congestive heart failure or exacerbation of chronic obstructive pulmonary disease.
Intervention: Comprehensive face-to-face medicine management consultation with an integrated practice pharmacist within seven days of discharge, followed by a consultation with their general practitioner and further pharmacist consultations as needed.
Major outcomes: Rates of unplanned, all-cause hospital re-admissions and emergency department (ED) presentations 12 months after hospital discharge; incremental net difference in overall costs.
Results: By 12 months, there had been 282 re-admissions among 177 control patients (incidence rate [IR], 1.65 per person-year) and 136 among 129 intervention patients (IR, 1.09 per person-year; fully adjusted IR ratio [IRR], 0.79; 95% CI, 0.52-1.18). ED presentation incidence (fully adjusted IRR, 0.46; 95% CI, 0.22-0.94) and combined re-admission and ED presentation incidence (fully adjusted IRR, 0.69; 95% CI, 0.48-0.99) were significantly lower for intervention patients. The estimated incremental net cost benefit of the intervention was $5072 per patient, with a benefit-cost ratio of 31:1.
Conclusion: A collaborative pharmacist-GP model of post-hospital discharge medicines management can reduce the incidence of hospital re-admissions and ED presentations, achieving substantial cost savings to the health system.
Leach AJ, Morris PS, Coates HL, et al.
Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children: summary of recommendations.
pp228-233. doi:10.5694/mja2.50953. PMID: 33641192.
Introduction: The 2001 Recommendations for clinical care guidelines on the management of otitis media in Aboriginal and Torres Islander populations were revised in 2010. This 2020 update by the Centre of Research Excellence in Ear and Hearing Health of Aboriginal and Torres Strait Islander Children used for the first time the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.
Main recommendations: We performed systematic reviews of evidence across prevention, diagnosis, prognosis and management. We report ten algorithms to guide diagnosis and clinical management of all forms of otitis media. The guidelines include 14 prevention and 37 treatment strategies addressing 191 questions.
Changes in management as a result of the guidelines: A GRADE approach is used. Targeted recommendations for both high and low risk children. New tympanostomy tube otorrhoea section. New Priority 5 for health services: annual and catch-up ear health checks for at-risk children. Antibiotics are strongly recommended for persistent otitis media with effusion in high risk children. Azithromycin is strongly recommended for acute otitis media where adherence is difficult or there is no access to refrigeration. Concurrent audiology and surgical referrals are recommended where delays are likely. Surgical referral is recommended for chronic suppurative otitis media at the time of diagnosis. The use of autoinflation devices is recommended for some children with persistent otitis media with effusion. Definitions for mild (21-30 dB) and moderate (> 30 dB) hearing impairment have been updated. New "OMapp" enables free fast access to the guidelines, plus images, animations, and multiple Aboriginal and Torres Strait Islander language audio translations to aid communication with families.
Swannell C.
Calendar of conferences in Australia and New Zealand.
C1-C2. doi:10.5694/mja2.50976. PMID: 33715188.
Milroy T, Bandler LG.
Closing the Gap: where to now?
pp209-210. doi:10.5694/mja2.50959. PMID: 33622017.
Fetene DM, Higgs P, Nielsen S, et al.
The impact of Victoria's real time prescription monitoring system (SafeScript) in a cohort of people who inject drugs.
p234.e1. doi:10.5694/mja2.50958. PMID: 33598989.
Dobbin M.
The impact of Victoria's real time prescription monitoring system (SafeScript) on a cohort of people who inject drugs.
p234.e1. doi:10.5694/mja2.50956. PMID: 33598935.
Snaith JR, Holmes-Walker DJ.
Technologies in the management of type 1 diabetes.
pp202-205.e1. doi:10.5694/mja2.50946. PMID: 33641181.
Der Sarkissian SA, Sebaratnam DF.
Darier sign in mastocytoma.
p206. doi:10.5694/mja2.50947. PMID: 33715187.
Ong WL, Foroudi F, Milne RL, et al.
Palliative radiotherapy for bone metastases at the end of life in Victoria.
pp236-237.e1. doi:10.5694/mja2.50954. PMID: 33610136.
Gunn MA, McDonald FJ.
COVID-19, rationing and the right to health: can patients bring legal actions if they are denied access to care?
pp207-208.e1. doi:10.5694/mja2.50952. PMID: 33618423.
Follent D, Paulson C, Orcher P, et al.
The indirect impacts of COVID-19 on Aboriginal communities across New South Wales.
pp199-200.e1. doi:10.5694/mja2.50948. PMID: 33641165.
Bennett NJ, Hoskins A, Worth LJ.
Influenza vaccination in aged care: improving uptake.
p234.e1. doi:10.5694/mja2.50955. PMID: 33610134.
Howell J, Ward JS, Davies J, et al.
Hepatocellular carcinoma in Indigenous Australians: a call to action.
pp201-202.e1. doi:10.5694/mja2.50961. PMID: 33608890.
Chew MS, Halliday T.
Notes from afar: reflections from two Australian intensivists in Sweden during the COVID-19 pandemic.
p235.e1. doi:10.5694/mja2.50949. PMID: 33608964.
New England Journal of Medicine Vol. 384 No. 9 March 4 2021
Kalil AC, Patterson TF, Mehta AK, et al.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
pp795-807. doi:10.1056/NEJMoa2031994. PMID: 33306283; PMCID: PMC7745180.
China L, Freemantle N, Forrest E, et al.
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
pp808-817. doi:10.1056/NEJMoa2022166. PMID: 33657293.
Wong F, Pappas SC, Curry MP, et al.
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
pp818-828. doi:10.1056/NEJMoa2008290. PMID: 33657294.
Choueiri TK, Powles T, Burotto M, et al.
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
pp829-841. doi:10.1056/NEJMoa2026982. PMID: 33657295.
Rubin EJ, Baden LR, Morrissey S.
Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment.
e46. doi:10.1056/NEJMe2103680. PMID: 33657301.
Amutah C, Greenidge K, Mante A, et al.
Misrepresenting Race - The Role of Medical Schools in Propagating Physician Bias.
pp872-878. doi:10.1056/NEJMms2025768. PMID: 33406326.
Bates ER.
Examination of the Neck Veins.
e29. doi:10.1056/NEJMc2100350. PMID: 33657307.
Thadanipon K, Assavapokee T.
Examination of the Neck Veins. Reply.
e29. doi:10.1056/NEJMc2100350. PMID: 33657308.
Sehn LH, Salles G.
Diffuse Large B-Cell Lymphoma.
pp842-858. doi:10.1056/NEJMra2027612. PMID: 33657296.
Ogunwole SM.
Without Sanctuary.
pp791-793. doi:10.1056/NEJMp2030623. PMID: 33657685.
Halley MC, Mangurian C.
Caring for the Caregivers - Covid-19 Vaccination for Essential Members of the Health Care Team.
e33. doi:10.1056/NEJMpv2101339. PMID: 33577149.
Markewitz RDH, Wandinger KP, Junker R.
Saliva for Detection of SARS-CoV-2.
e31. doi:10.1056/NEJMc2032165. PMID: 33534973.
Wyllie AL, Vogels CBF, Grubaugh ND.
Saliva for Detection of SARS-CoV-2. Reply.
e31. doi:10.1056/NEJMc2032165. PMID: 33534974.
Garcia-Tsao G.
Terlipressin and Intravenous Albumin in Advanced Cirrhosis - Friend and Foe.
pp869-871. doi:10.1056/NEJMe2034425. PMID: 33657300.
Jilg N, Lau ES, Baker MA, et al.
A Treacherous Course.
pp860-865. doi:10.1056/NEJMcps2020668. PMID: 33657298.
Goletti D, Cantini F.
Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.
pp867-869. doi:10.1056/NEJMe2034982. PMID: 33657299.
Lacout A, Perronne C, Lounnas V.
Hydroxychloroquine in Hospitalized Patients with Covid-19.
pp881-882. doi:10.1056/NEJMc2035374. PMID: 33567187.
Horby P, White NJ, Landray MJ.
Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
p882. doi:10.1056/NEJMc2035374. PMID: 33567188.
Darouich S, Masmoudi A.
Tracheal Agenesis with Bronchoesophageal Fistula.
e27. doi:10.1056/NEJMicm2027782. PMID: 33657297.
Margolis B, Quartararo P, Wabnitz S.
Banning Genetic Discrimination in Life Insurance.
e30. doi:10.1056/NEJMc2035871. PMID: 33657310.
VanDommelen D.
Banning Genetic Discrimination in Life Insurance.
e30. doi:10.1056/NEJMc2035871. PMID: 33657309.
Rothstein MA, Brothers KB.
Banning Genetic Discrimination in Life Insurance. Reply.
e30. doi:10.1056/NEJMc2035871. PMID: 33657311.
Bent S, O'Malley MJ.
Diagnosis of Achilles' Tendon Rupture during a Virtual Examination.
p859. doi:10.1056/NEJMicm2029689. PMID: 33657684.
Gibbons GH, Seidman CE, Topol EJ.
Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
pp785-788. doi:10.1056/NEJMp2033115. PMID: 33657686.
Pata F, Podda M, Di Saverio S.
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis.
pp880. doi:10.1056/NEJMc2035865. PMID: 33657304.
Karaismailoglu B.
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis.
pp879-880. doi:10.1056/NEJMc2035865. PMID: 33657303.
LoVecchio F.
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis.
p879. doi:10.1056/NEJMc2035865. PMID: 33657302.
Bertrand MM, Lefrant JY, Prudhomme M.
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis.
pp880-881. doi:10.1056/NEJMc2035865. PMID: 33657305.
Bizzell B, Kessler LG; CODA Collaborative.
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis. Reply.
p881. doi:10.1056/NEJMc2035865. PMID: 33657306.
Kadire SR, Wachter RM, Lurie N.
Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
e28. doi:10.1056/NEJMclde2101987. PMID: 33596347.
Goroll AH, Greiner AC, Schoenbaum SC.
Reform of Payment for Primary Care - From Evolution to Revolution.
pp788-791. doi:10.1056/NEJMp2031640. PMID: 33596353.
New England Journal of Medicine Vol. 384 No. 10 March 11 2021
ACTIV-3/TICO LY-CoV555 Study Group, Lundgren JD, Grund B, et al.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
pp905-914. doi:10.1056/NEJMoa2033130. PMID: 33356051; PMCID: PMC7781100.
Seikaly H.
Epistaxis.
pp944-951. doi:10.1056/NEJMcp2019344. PMID: 33704939.
Rubin EJ, Baden LR, Abraham J, et al.
Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
e48. doi:10.1056/NEJMe2104138. PMID: 33704945.
Hillier TA, Pedula KL, Ogasawara KK, et al.
A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening.
pp895-904. doi:10.1056/NEJMoa2026028. PMID: 33704936.
Baranello G, Darras BT, Day JW, et al.
Risdiplam in Type 1 Spinal Muscular Atrophy.
pp915-923. doi:10.1056/NEJMoa2009965. PMID: 33626251.
Usui H, Shozu M.
Spermatogonium-Derived Complete Hydatidiform Mole.
pp936-943. doi:10.1056/NEJMoa2005756. PMID: 33704938.
Duncavage EJ, Schroeder MC, O'Laughlin M, et al.
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
pp924-935. doi:10.1056/NEJMoa2024534. PMID: 33704937.
Carter S.
Breathless.
pp891-893. doi:10.1056/NEJMp2032522. PMID: 33705618.
Van Tassel K, Shachar C, Hoffman S.
Covid-19 Vaccine Injuries - Preventing Inequities in Compensation.
e34. doi:10.1056/NEJMp2034438. PMID: 33471973.
Poole MK, Fleischhacker SE, Bleich SN.
Addressing Child Hunger When School Is Closed - Considerations during the Pandemic and Beyond.
e35. doi:10.1056/NEJMp2033629. PMID: 33471976.
Niederer RL, Al-Ani HH.
Bartonella Neuroretinitis.
p952. doi:10.1056/NEJMicm2005549. PMID: 33705615.
Casey B.
Gestational Diabetes - On Broadening the Diagnosis.
pp965-966. doi:10.1056/NEJMe2100902. PMID: 33704942.
Butler PC.
Supplying Insulin while Evading Immunity.
pp967-969. doi:10.1056/NEJMcibr2028410. PMID: 33704943.
Battistuzzi L, Puccini A, Sciallero S.
Microsatellite-Instability-High Advanced Colorectal Cancer.
pp971-972. doi:10.1056/NEJMc2036233. PMID: 33704946.
Sorscher S.
Microsatellite-Instability-High Advanced Colorectal Cancer.
p972. doi:10.1056/NEJMc2036233. PMID: 33704947.
Diaz LA, Le DT, André T.
Microsatellite-Instability-High Advanced Colorectal Cancer. Reply.
pp972-973. doi:10.1056/NEJMc2036233. PMID: 33704948.
Rolla G, Brussino L, Badiu I.
Maintaining Safety with SARS-CoV-2 Vaccines.
e37. doi:10.1056/NEJMc2100766. PMID: 33567189.
Castells MC, Phillips EJ.
Maintaining Safety with SARS-CoV-2 Vaccines. Reply.
e37. doi:10.1056/NEJMc2100766. PMID: 33567190.
Bylicki O, Paleiron N, Janvier F.
An Outbreak of Covid-19 on an Aircraft Carrier.
p976. doi:10.1056/NEJMc2034424. PMID: 33567182.
Kasper MR, Geibe JR.
An Outbreak of Covid-19 on an Aircraft Carrier. Reply.
pp976-977. doi:10.1056/NEJMc2034424. PMID: 33567183.
Günther G, Einbeck C.
Pulmonary Alveolar Microlithiasis Complicated by Tuberculosis.
e36. doi:10.1056/NEJMicm2028047. PMID: 33704940.
Eke AC.
Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy.
p977. doi:10.1056/NEJMc2101226. PMID: 33704954.
Pennell PB, Meador KJ.
Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy. Reply.
pp977-978. doi:10.1056/NEJMc2101226. PMID: 33704955.
Duraes AR, Bitar YSL.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
p975. doi:10.1056/NEJMc2035891. PMID: 33704952.
Verma A, Dhingra N, Yanagawa B.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
pp973-974. doi:10.1056/NEJMc2035891. PMID: 33704949.
Lotlikar A, Anwar S.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
p974. doi:10.1056/NEJMc2035891. PMID: 33704950.
Alghamry A, Lee JC.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
pp974-975. doi:10.1056/NEJMc2035891. PMID: 33704951.
Berwanger O, Guimarães HP, Lopes RD.
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply.
pp975-976. doi:10.1056/NEJMc2035891. PMID: 33704953.
Kasner SE, Rhodes JF, Andersen G, et al.
Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke.
pp970-971. doi:10.1056/NEJMc2033779. PMID: 33704944.
Haque OS, Stein MA, Marvit A.
Physician, Heal Thy Double Stigma – Doctors with Mental Illness and Structural Barriers to Disclosure.
pp888-891. doi:10.1056/NEJMp2031013. PMID: 33705616.
Bendapudi PK, Whalen MJ, Lahoud-Rahme M, et al.
Case 7-2021: A 19-Year-Old Man with Shock, Multiple Organ Failure, and Rash.
pp953-963. doi:10.1056/NEJMcpc2027093. PMID: 33704941.
Ubel PA.
Vaccinating Health Care Employees - Do They All Deserve Early Access?
e39. doi:10.1056/NEJMpv2101203. PMID: 33606365.
Rastogi S.
Establishing Equity in Medical Education - Supporting Clinical Trainees with Disabilities.
pp885-887. doi:10.1056/NEJMp2035279. PMID: 33705617.
New England Journal of Medicine Vol. 384 No. 11 March 18 2021
Joyner MJ, Carter RE, Senefeld JW, et al.
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
pp1015-1027. doi:10.1056/NEJMoa2031893. PMID: 33523609; PMCID: PMC7821984.
Corey L, Gilbert PB, Juraska M, et al.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
pp1003-1014. doi:10.1056/NEJMoa2031738. PMID: 33730454.
Wilding JPH, Batterham RL, Calanna S, et al.
Once-Weekly Semaglutide in Adults with Overweight or Obesity.
p989. doi:10.1056/NEJMoa2032183. PMID: 33567185.
Hillmen P, Szer J, Weitz I, et al.
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.
pp1028-1037. doi:10.1056/NEJMoa2029073. PMID: 33730455.
Slagstad K.
The Political Nature of Sex - Transgender in the History of Medicine.
doi:1070-1074. doi:10.1056/NEJMms2029814. PMID: 33534975.
Vergnes JN.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
doi:10.1056/NEJMc2036242#sa2. doi:10.1056/NEJMc2036242. PMID: 33596349.
Wang X.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
doi:10.1056/NEJMc2036242#sa3. doi:10.1056/NEJMc2036242. PMID: 33596350.
Skowronski DM, De Serres G.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
doi:10.1056/NEJMc2036242#sa1. doi:10.1056/NEJMc2036242. PMID: 33596348.
Absalon J, Koury K, Gruber WC.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
doi:10.1056/NEJMc2036242#sa4. doi:10.1056/NEJMc2036242. PMID: 33596351.
Cacoub P, Saadoun D.
Extrahepatic Manifestations of Chronic HCV Infection.
pp1038-1052. doi:10.1056/NEJMra2033539. PMID: 33730456.
Leiter RE.
My Intern.
pp986-987. doi:10.1056/NEJMp2004154. PMID: 33734648.
Thammavaranucupt K, Spanuchart I.
Sulfonamide Crystals.
p1053. doi:10.1056/NEJMicm2028020. PMID: 33734650.
Su Q, Wang F.
Painful Nodules on the Arms.
e41. doi:10.1056/NEJMicm2028530. PMID: 33730457.
Walker BD.
The AMP Trials - A Glass Half Full.
pp1068-1069. doi:10.1056/NEJMe2101131. PMID: 33730459.
Rubin EJ, Baden LR, Morrissey S.
Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
e53. doi:10.1056/NEJMe2104584. PMID: 33730461.
Wang X, Ge J.
Spontaneous Coronary-Artery Dissection.
p1077. doi:10.1056/NEJMc2100339. PMID: 33730463.
Campochiaro C, Tomelleri A, Dagna L.
Spontaneous Coronary-Artery Dissection.
p1077. doi:10.1056/NEJMc2100339. PMID: 33730462.
Kim ESH.
Spontaneous Coronary-Artery Dissection. Reply.
pp1077-1078. doi:10.1056/NEJMc2100339. PMID: 33730464.
Ingelfinger JR, Rosen CJ.
STEP 1 for Effective Weight Control – Another First Step?
pp1066-1067. doi:10.1056/NEJMe2101705. PMID: 33567184.
Rosenbaum S, Hawkins DR.
The Good Doctor - Jack Geiger, Social Justice, and U.S. Health Policy.
pp983-985. doi:10.1056/NEJMp2036296. PMID: 33734649.
Moura-Neto JA, Ronco C.
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
e42. doi:10.1056/NEJMc2036175. PMID: 33730469.
Young MJ, Fuller PJ.
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
e42. doi:10.1056/NEJMc2036175. PMID: 33730468.
Edwards NC, Ferro CJ, Townend JN.
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
e42. doi:10.1056/NEJMc2036175. PMID: 33730467.
Makembi AB, Mohamadou I, Galichon P.
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
e42. doi:10.1056/NEJMc2036175. PMID: 33730466.
Baumstein D.
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
e42. doi:10.1056/NEJMc2036175. PMID: 33730465.
Bakris GL, Agarwal R, Filippatos G.
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply.
e42. doi:10.1056/NEJMc2036175. PMID: 33730470.
Goyal L, Chen CT, Pierce TT, et al.
Case 8-2021: A 34-Year-Old Woman with Cholangiocarcinoma.
pp1054-1064. doi:10.1056/NEJMcpc2027092. PMID: 33730458.
Kauke M, Panayi AC, Tchiloemba B, et al.
Face Transplantation in a Black Patient - Racial Considerations and Early Outcomes.
pp1075-1076. doi:10.1056/NEJMc2033961. PMID: 33730460.
Zhu JM, Polsky D.
Private Equity and Physician Medical Practices - Navigating a Changing Ecosystem.
pp981-983. doi:10.1056/NEJMp2032115. PMID: 33734651.
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- austrian syndrome ceftriaxone induced agranulocytosis and
- conditions contributing to deaths involving covid 19 by
- covid 19 astrazeneca vaccine analysis print
- nh covid 19 vaccination allocation guidelines for phase 1b
- heartbeat higher risk of covid 19 infection in younger
- severe acute mitral valve regurgitation in a covid 19
- homepage sts
- syllabus quiz 1
- print clearly
- patient registration kings highway oms
Related searches
- australian department of education
- royal sync university of scranton
- female general practitioners near me
- royal bank line of credit
- australian journal of linguistics
- australian review of applied linguistics
- australian journal of applied linguistics
- australian office of national intelligence
- australian journal of soil research
- australian timeline of important events
- australian journal of botany journal
- australian code of arms